Timesulin Ltd
Effortless insulin management with a smart timer-enabled cap for all standard insulin pens.
Effortless insulin management with a smart timer-enabled cap for all standard insulin pens.
Timesulin Ltd offers a solution for effortless insulin management with a smart timer-enabled cap designed for all standard insulin pens. The company, founded in 2010 and headquartered in the United Kingdom, addresses the challenge of insulin-dependent individuals forgetting to take their insulin, which can lead to health risks. The patented technology used in the product is compatible with any insulin pen, requires no disruption to the user's routine, and is designed to be user-friendly for individuals of all ages. It is a Class 1 medical device approved for commercialization and patented. Timesulin is manufactured in Germany and has been selectively launched through a network of independent distributors, pharmacists, and its website. The company secured a seed round investment on 01 August 2013 from Estag Capital, a notable investment in the medical devices industry. For more information, visit their website at www.timesulin.com.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 | Estag Capital | 01 Aug 2013 |
No recent news or press coverage available for Timesulin Ltd.
We care about your data, and we'd love to use cookies make your experience better.
